Anti-inflammatory effects of a fluorovinyloxyacetamide compound KT-15087 in microglia cells

Pharmacological Research

Volumn 59, Issue 6, 2009, Pages 414-422

  Ock, Jiyeon ^a   Kim, Sangseop ^a   Suk, Kyoungho ^a  

^a CMRI   (South Korea)

Author keywords

Fluorovinyloxyacetamide compounds; Microglia; Neurodegenerative disease; Neuroinflammation; Neuroprotection

Indexed keywords

ACETAMIDE DERIVATIVE; FLUOROVINYLOXYACETAMIDE DERIVATIVE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; KT 15082; KT 15087; KT 16552; KT 16558; KT 16600; KT 16625; KT 17507; KT 17508; KT 17510; LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE; NITRITE; STRESS ACTIVATED PROTEIN KINASE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL VIABILITY; COCULTURE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME PHOSPHORYLATION; GEL MOBILITY SHIFT ASSAY; GENE EXPRESSION; MICROGLIA; NERVE CELL NECROSIS; NEUROBLASTOMA CELL; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STATISTICAL ANALYSIS; WESTERN BLOTTING;

ACETAMIDES; ANIMALS; ANTI-INFLAMMATORY AGENTS; BLOTTING, WESTERN; CELL LINE, TUMOR; CELL SURVIVAL; COCULTURE TECHNIQUES; JNK MITOGEN-ACTIVATED PROTEIN KINASES; LIPOPOLYSACCHARIDES; MICE; MICROGLIA; NEUROPROTECTIVE AGENTS; NF-KAPPA B; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; P38 MITOGEN-ACTIVATED PROTEIN KINASES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR NECROSIS FACTOR-ALPHA; VINYL COMPOUNDS;

EID: 65049084462     PISSN: 10436618     EISSN: 10961186     Source Type: Journal    
DOI: 10.1016/j.phrs.2009.02.008     Document Type: Article

References (52)

1. Block M.L., Zecca L., and Hong J.S. Microglia-mediated neurotoxicity: uncovering the molecular mechanisms. Nat Rev Neurosci 8 (2007) 57-69
2. Liu B., and Hong J.S. Role of microglia in inflammation-mediated neurodegenerative diseases: mechanisms and strategies for therapeutic intervention. J Pharmacol Exp Ther 304 (2003) 1-7
3. McGeer E.G., and McGeer P.L. Inflammatory processes in Alzheimer's disease. Prog Neuropsychopharmacol Biol Psychiatry 27 (2003) 741-749
4. Aldskogius H., Liu L., and Svensson M. Glial responses to synaptic damage and plasticity. J Neurosci Res 58 (1999) 33-41
5. McGeer P.L., Schwab C., Parent A., and Doudet D. Presence of reactive microglia in monkey substantia nigra years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine administration. Ann Neurol 54 (2003) 599-604
6. Pawate S., Shen Q., Fan F., and Bhat N.R. Redox regulation of glial inflammatory response to lipopolysaccharide and interferongamma. J Neurosci Res 77 (2004) 540-551
7. Qin L., Liu Y., Wang T., Wei S.J., Block M.L., Wilson B., et al. NADPH oxidase mediates lipopolysaccharide-induced neurotoxicity and proinflammatory gene expression in activated microglia. J Biol Chem 279 (2004) 1415-1421
8. Bamberger M.E., Harris M.E., McDonald D.R., Husemann J., and Landreth G.E. A cell surface receptor complex for fibrillar beta-amyloid mediates microglial activation. J Neurosci 23 (2003) 2665-2674
9. Wilkinson B., Koenigsknecht-Talboo J., Grommes C., Lee C.Y., and Landreth G. Fibrillar beta-amyloid-stimulated intracellular signaling cascades require Vav for induction of respiratory burst and phagocytosis in monocytes and microglia. J Biol Chem 281 (2006) 20842-20850
10. Inoue K. Microglial activation by purines and pyrimidines. Glia 40 (2002) 156-163
11. Zhang W., Wang T., Pei Z., Miller D.S., Wu X., Block M.L., et al. Aggregated alpha-synuclein activates microglia: a process leading to disease progression in Parkinson's disease. FASEB J 19 (2005) 533-542
12. Croisier E., and Graeber M.B. Glial degeneration and reactive gliosis in alpha-synucleinopathies: the emerging concept of primary gliodegeneration. Acta Neuropathol 112 (2006) 517-530
13. Min K.J., Pyo H.K., Yang M.S., Ji K.A., Jou I., and Joe E.H. Gangliosides activate microglia via protein kinase C and NADPH oxidase. Glia 48 (2004) 197-206
14. Choi S.H., Joe E.H., Kim S.U., and Jin B.K. Thrombin-induced microglial activation produces degeneration of nigral dopaminergic neurons in vivo. J Neurosci 23 (2003) 5877-5886
15. Choi S.H., Lee D.Y., Kim S.U., and Jin B.K. Thrombin-induced oxidative stress contributes to the death of hippocampal neurons in vivo: role of microglial NADPH oxidase. J Neurosci 25 (2005) 4082-4090
16. Kim Y.S., Choi D.H., Block M.L., Lorenzl S., Yang L., Kim Y.J., et al. A pivotal role of matrix metalloproteinase-3 activity in dopaminergic neuronal degeneration via microglial activation. FASEB J 21 (2007) 179-187
17. Kim Y.S., Kim S.S., Cho J.J., Choi D.H., Hwang O., Shin D.H., et al. Matrix metalloproteinase-3: a novel signaling proteinase from apoptotic neuronal cells that activates microglia. J Neurosci 25 (2005) 3701-3711
18. Giulian D., Li J., Li X., George J., and Rutecki P.A. The impact of microglia-derived cytokines upon gliosis in the CNS. Dev Neurosci 16 (1994) 128-136
19. Zielasek J., and Hartung H.P. Molecular mechanisms of microglial activation. Adv Neuroimmunol 6 (1996) 122-191
20. Gonzalez-Scarano F., and Baltuch G. Microglia as mediators of inflammatory and degenerative diseases. Annu Rev Neurosci 22 (1999) 219-240
21. Minghetti Land Levi G. Microglia as effector cells in brain damage and repair: focus on prostanoids and nitric oxide. Prog Neurobiol 54 (1998) 99-125
22. McGeer P.L., Itagaki S., Boyes B.E., and McGeer E.G. Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains. Neurology 38 (1988) 1285-1291
23. McGeer P.L., and McGeer E.G. Inflammation and neurodegeneration in Parkinson's disease. Parkinsonism Relat Disord 10 Suppl. 1 (2004) S3-7
24. Blasi E., Barluzzi R., Bocchini V., Mazzolla R., and Bistoni F. Immortalization of murine microglial cells by a v-raf/v-myc carrying retrovirus. J Neuroimmunol 27 (1990) 229-237
25. Bocchini V., Mazzolla R., Barluzzi R., Blasi E., Sick P., and Kettenmann H. An immortalized cell line expresses properties of activated microglial cells. J Neurosci Res 31 (1992) 616-621
26. Cheepsunthorn P., Radov L., Menzies S., Reid J., and Connor J.R. Characterization of a novel brain-derived microglial cell line isolated from neonatal rat brain. Glia 35 (2001) 53-62
27. Schubert D., Heinemann S., Carlisle W., Tarikas H., Kimes B., Patrick J., et al. Clonal cell lines from the rat central nervous system. Nature 249 (1974) 224-227
28. Saura J., Tusell J.M., and Serratosa J. High-yield isolation of murine microglia by mild trypsinization. Glia 44 (2003) 183-189
29. Ock J., Lee H., Kim S., Lee W.H., Choi D.K., Park E.J., et al. Induction of microglial apoptosis by corticotropin-releasing hormone. J Neurochem 98 (2006) 962-972
30. Zheng L.T., Ock J., Kwon B.M., and Suk K. Suppressive effects of flavonoid fisetin on lipopolysaccharide-induced microglial activation and neurotoxicity. Int Immunopharmacol 8 (2008) 484-494
31. Schreiber E., Matthias P., Muller M.M., and Schaffner W. Rapid detection of octamer binding proteins with 'mini-extracts', prepared from a small number of cells. Nucleic Acids Res 17 (1989) 6419
32. Chang L.C., Tsao L.T., Chang C.S., Chen C.J., Huang L.J., Kuo S.C., et al. Inhibition of nitric oxide production by the carbazole compound LCY-2-CHO via blockade of activator protein-1 and CCAAT/enhancer-binding protein activation in microglia. Biochem Pharmacol 76 (2008) 507-519
33. Meng X.L., Yang J.Y., Chen G.L., Zhang L.J., Wang L.H., Li J., et al. RV09, a novel resveratrol analogue, inhibits NO and TNF-alpha production by LPS-activated microglia. Int Immunopharmacol 8 (2008) 1074-1082
34. Walter S., Letiembre M., Liu Y., Heine H., Penke B., Hao W., et al. Role of the toll-like receptor 4 in neuroinflammation in Alzheimer's disease. Cell Physiol Biochem 20 (2007) 947-956
35. Baeuerle P.A., and Henkel T. Function and activation of NF-kappa B in the immune system. Annu Rev Immunol 12 (1994) 141-179
36. Mukaida N., Ishikawa Y., Ikeda N., Fujioka N., Watanabe S., Kuno K., et al. Novel insight into molecular mechanism of endotoxin shock: biochemical analysis of LPS receptor signaling in a cell-free system targeting NF-kappaB and regulation of cytokine production/action through beta2 integrin in vivo. J Leukocyte Biol 59 (1996) 145-151
37. Koistinaho M., and Koistinaho J. Role of p38 and p44/42 mitogen-activated protein kinases in microglia. Glia 40 (2002) 175-183
38. Stoll G., and Jander S. The role of microglia and macrophages in the pathophysiology of the CNS. Prog Neurobiol 58 (1999) 233-247
39. Streit W.J., Walter S.A., and Pennell N.A. Reactive microgliosis. Prog Neurobiol 57 (1999) 563-581
40. Matsumoto H. Proceedings I (A). Weed and environmental impact. The 17th Asian-Pacific weed science society conference. Bangkok, Thailand (November 1999) 39
41. Cho D. Quantitative structure-activity relationship (QSAR) study of new fluorovinylacetamides. Bull Korean Chem Soc 22 (2001) 388-394
42. Jongeneel C.V. Transcriptional regulation of the tumor necrosis factor alpha gene. Immunobiology 193 (1995) 210-216
43. Streit W.J. Microglia and the response to brain injury. Ernst Schering Res Foundation Workshop 39 (2002) 11-24
44. i transients and changes the organization of actin in microglia. Glia 11 (1994) 336-344
45. Abd-el-Basset E., and Fedoroff S. Effect of bacterial wall lipopolysaccharide (LPS) on morphology, motility, and cytoskeletal organization of microglia in cultures. J Neurosci Res 41 (1995) 222-237
46. Huang Z.J., Haugland R.P., You W.M., and Haugland R.P. Phallotoxin and actin binding assay by fluorescence enhancement. Anal Biochem 200 (1992) 199-204
47. Faulstich H., Zobeley S., Heintz D., and Drewes G. Probing the phalloidin binding site of actin. FEBS Lett 318 (1993) 218-222
48. Fiebich B.L., Lieb K., Engels S., and Heinrich M. Inhibition of LPS-induced p42/44 MAP kinase activation and iNOS/NO synthesis by parthenolide in rat primary microglial cells. J Neuroimmunol 132 (2002) 18-24
49. Lim G.P., Yang F., Chu T., Chen P., Beech W., Teter B., et al. Ibuprofen suppresses plaque pathology and inflammation in a mouse model for Alzheimer's disease. J Neurosci 20 (2000) 5709-5714
50. Suk K. Proteomics-based discovery of biomarkers and therapeutic targets in neurodegenerative diseases: perspective of microglia and neuroinflammation. Exp Opin Ther Patents 16 (2006) 237-247
51. Wyss-Coray T. Inflammation in Alzheimer disease: driving force, bystander or beneficial response?. Nat Med 12 (2006) 1005-1015
52. Kim S., Ock J., Kim A.K., Lee H.W., Cho J.Y., Kim D.R., et al. Neurotoxicity of microglial cathepsin D revealed by secretome analysis. J Neurochem 103 (2007) 2640-2650